ICTUImperial Clinical Trials Unit

  • Kausik Ray

Back to Team

Kausik Ray

Deputy Director of ICTU

Kausik Ray is a Professor of Public Health at Imperial College London, as well as Honorary Consultant Cardiologist at the Imperial College NHS Trust. He is Deputy Director of ICTU and Head of the Commercial Portfolio. With effect from 1st January 2020, Kosh is President-Elect of the European Atherosclerosis Society. After a one year handover, he will then take over formal Presidential duties from 1st January 2021 for 4 years. In Oct 2019, he became Clinical Director for DISCOVER NOW, the Health Data Research (HDR) UK hub for North West London providing integrated data for observational studies and real world trials in over 2.3 million people. Also from Oct 2019, Kosh became the National Lead for Cardiovascular Disease for the National Institute for Health Research (NIHR) Academic Research Collaboration (ARC).   

Kosh's research interests have focused on the prevention of cardiovascular disease with a special interest in lipids and diabetes using population health approaches. These include use for routine healthcare data, bespoke/ opportunistic registries and clinical trials. His work has influenced AHA/ACC/ESC and national guidelines as well as impacting global label changes at the level of the FDA and EMEA and authorisation for novel therapies.  

Currently Kosh leads the EAS Familial Hypercholesterolaemia (FH) Studies collaboration which is the first global registry for FH and now includes approximately seventy countries with more than 61 000 cases, and he is the Senior PI for the TOGETHER study looking at cardiometabolic risk in the vascular health checks in 250,000 people in London. Kosh has served on the Steering, Executive committees, DSMB and CEC for several major global medical trials, including acting as the global PI of DAL ACUTE, CLEAR HARMONY, ORION 1, 3, 11 and BETONMACE. His work has been published in NEJM, Lancet and JAMA and recognised by Clarivate Analytics in 2018 and 2019 as among the top 1% of publications cited globally in clinical medicine produced by the top 0.1% of authors globally.

Imperial Profile